PICO Portalanswers from OpenAlex
Navarre Institute of Health Research
InstitutionResearch output, impact & collaborations
Navarre Institute of Health Research is a institution indexed in PICO Portal from OpenAlex.
What is known about Navarre Institute of Health Research?
PICO Portalrecord summary
Navarre Institute of Health Research is a research organisation in Pamplona, ES. OpenAlex records 6,933 works and 597,818 citations for it. 1,727 researchers list it as their most recent affiliation.
How many works does Navarre Institute of Health Research have?
PICO Portalindexed works
Navarre Institute of Health Research has 6,933 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Navarre Institute of Health Research have?
PICO Portalcitation count
Navarre Institute of Health Research has 597,818 citations in the OpenAlex counts PICO Portal stores.
How many researchers are at Navarre Institute of Health Research?
PICO Portalresearcher count
Navarre Institute of Health Research has 1,727 researchers in the PICO Portal index.
What is the average h-index at Navarre Institute of Health Research?
PICO Portalavg h-index
Navarre Institute of Health Research has an average h-index of 82 in OpenAlex.
What is the ROR of Navarre Institute of Health Research?
PICO Portalror
The ROR for Navarre Institute of Health Research is on the source record.
What is the OpenAlex record for Navarre Institute of Health Research?
PICO Portalopenalex
The OpenAlex for Navarre Institute of Health Research is on the source record.
Who are the most-cited researchers behind Navarre Institute of Health Research?
PICO Portaltop researchers by citations
What are the most-cited papers on Navarre Institute of Health Research?
PICO Portalmost cited works
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
JJM van Dongen, EA Macintyre, J Gäbert, Éric Delabesse, V Rossi, Giuseppe Saglio, Enrico Gottardi, Alessandro Rambaldi, Gianpietro Dotti, Frank Griesinger, A Parreira, Paula Gameiro, M González Diáz, M Malec, A W Langerak, Jesús F. San Miguel, Andrea Biondi
Teclistamab in Relapsed or Refractory Multiple Myeloma
Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk, Hareth Nahi, Jesús F. San Miguel, Albert Oriol, Ajay K. Nooka, Thomas G. Martin, Laura Rosiñol, Ajai Chari, Lionel Karlin, Lotfi Benboubker, María‐Victoria Mateos, Nizar J. Bahlis, Rakesh Popat, Britta Besemer, Joaquín Martínez‐López, Surbhi Sidana, Michel Delforge, Lixia Pei, Danielle Trancucci, Raluca Verona, Suzette Girgis, Shun Xin Wang Lin, Yunsi Olyslager, Mindy Jaffe, Clarissa Uhlar, Tara Stephenson, Rian Van Rampelbergh, Arnob Banerjee, Jenna D. Goldberg, Rachel Kobos, Amrita Krishnan, Saad Z. Usmani
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Sagar Lonial, Hans C. Lee, Ashraf Badros, Suzanne Trudel, Ajay K. Nooka, Ajai Chari, Al‐Ola Abdallah, Natalie S. Callander, Nikoletta Lendvai, Douglas W. Sborov, Attaya Suvannasankha, Katja Weisel, Lionel Karlin, Edward N. Libby, Bertrand Arnulf, Thierry Façon, Cyrille Hulin, K. Martin Kortüm, Paula Rodríguez‐Otero, Saad Z. Usmani, Parameswaran Hari, Rachid Baz, Hang Quach, Philippe Moreau, Peter M. Voorhees, Ira Gupta, Axel Hoos, Eric Zhi, January Baron, Trisha Piontek, Eric Lewis, Roxanne C. Jewell, Elisha J. Dettman, Rakesh Popat, Simona Degli Esposti, Joanna Opalinska, Paul G. Richardson, Adam D. Cohen
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
Paula Rodríguez‐Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel, Michèle Cavo, Ajay K. Nooka, Salomon Manier, Natalie S. Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott R. Solomon, Michel Delforge, Jesús G. Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre‐Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt
How much of the research on Navarre Institute of Health Research is open access?
PICO Portalopen access share
67%OPEN ACCESS